Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) - Investment analysts at Roth Capital decrease...
Raymond James Financial lifted their price target on Zimmer Biomet from $104.00 to $113.00 and gave ...
ASR Vermogensbeheer N.V. bought a new stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Fr...
Latest Ratings for ZBH DateFirmActionFromTo Mar 2022Loop CapitalDowngradesBuyHold Feb 2022Loop Capit...